{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "ABIO",
        "Security_Name": "ARCA biopharma, Inc. - Common Stock",
        "Listing_Exchange": "Q",
        "Market_Category": "S",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "N",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "ABIO",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 4,
        "previousClose": 2.48,
        "open": 2.46,
        "dayLow": 2.46,
        "dayHigh": 2.6999,
        "regularMarketPreviousClose": 2.48,
        "regularMarketOpen": 2.46,
        "regularMarketDayLow": 2.46,
        "regularMarketDayHigh": 2.6999,
        "payoutRatio": 0,
        "beta": 1.781609,
        "forwardPE": -0.28977272,
        "volume": 153888,
        "regularMarketVolume": 153888,
        "averageVolume": 34601,
        "averageVolume10days": 66670,
        "averageDailyVolume10Day": 66670,
        "bid": 2.52,
        "ask": 2.59,
        "bidSize": 800,
        "askSize": 1100,
        "marketCap": 36745756,
        "fiftyTwoWeekLow": 1.71,
        "fiftyTwoWeekHigh": 2.7,
        "fiftyDayAverage": 2.1872,
        "twoHundredDayAverage": 2.2882,
        "trailingAnnualDividendRate": 0,
        "trailingAnnualDividendYield": 0,
        "currency": "USD",
        "fromCurrency": null,
        "toCurrency": null,
        "lastMarket": null,
        "coinMarketCapLink": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "3Q2019",
                    "actual": -0.76,
                    "estimate": -1.3
                },
                {
                    "date": "4Q2019",
                    "actual": -0.77,
                    "estimate": -0.99
                },
                {
                    "date": "1Q2020",
                    "actual": -0.83,
                    "estimate": -2.04
                },
                {
                    "date": "2Q2020",
                    "actual": -0.73,
                    "estimate": -2.58
                }
            ],
            "currentQuarterEstimateDate": "3Q",
            "currentQuarterEstimateYear": 2020,
            "earningsDate": [
                1678738500,
                1679084100
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 0,
                    "earnings": -7933000
                },
                {
                    "date": 2019,
                    "revenue": 0,
                    "earnings": -5482000
                },
                {
                    "date": 2020,
                    "revenue": 0,
                    "earnings": -9738000
                },
                {
                    "date": 2021,
                    "revenue": 0,
                    "earnings": -19322000
                }
            ],
            "quarterly": [
                {
                    "date": "4Q2021",
                    "revenue": 0,
                    "earnings": -5676000
                },
                {
                    "date": "1Q2022",
                    "revenue": 0,
                    "earnings": 0
                },
                {
                    "date": "2Q2022",
                    "revenue": 0,
                    "earnings": -3147000
                },
                {
                    "date": "3Q2022",
                    "revenue": 0,
                    "earnings": -2333000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1678738500,
                1679084100
            ]
        },
        "dividendDate": "2019-04-04T00:00:00.000Z"
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2020-11-25T09:35:50.000Z",
                "firm": "Dawson James",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "DELAYED",
        "postMarketChangePercent": 0.00784313,
        "postMarketChange": 0.02,
        "postMarketTime": "2023-01-06T23:46:29.000Z",
        "postMarketPrice": 2.57,
        "postMarketSource": "FREE_REALTIME",
        "regularMarketChangePercent": 0.02822578,
        "regularMarketChange": 0.06999993,
        "regularMarketTime": "2023-01-06T20:59:55.000Z",
        "priceHint": 4,
        "regularMarketPrice": 2.55,
        "regularMarketDayHigh": 2.6999,
        "regularMarketDayLow": 2.46,
        "regularMarketVolume": 153888,
        "averageDailyVolume10Day": 66670,
        "averageDailyVolume3Month": 34601,
        "regularMarketPreviousClose": 2.48,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 2.46,
        "exchange": "NCM",
        "exchangeName": "NasdaqCM",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "ABIO",
        "underlyingSymbol": null,
        "shortName": "ARCA biopharma, Inc.",
        "longName": "ARCA biopharma, Inc.",
        "currency": "USD",
        "quoteSourceName": "Nasdaq Real Time Price",
        "currencySymbol": "$",
        "fromCurrency": null,
        "toCurrency": null,
        "lastMarket": null,
        "marketCap": 36745756
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 4,
        "enterpriseValue": -7936947,
        "profitMargins": 0,
        "floatShares": 9540667,
        "sharesOutstanding": 14410100,
        "sharesShort": 51836,
        "sharesShortPriorMonth": 50508,
        "sharesShortPreviousMonthDate": 1668470400,
        "dateShortInterest": 1671062400,
        "sharesPercentSharesOut": 0.0036000002,
        "heldPercentInsiders": 0.012990001,
        "heldPercentInstitutions": 0.38636002,
        "shortRatio": 2.07,
        "shortPercentOfFloat": 0.0044,
        "beta": 1.781609,
        "impliedSharesOutstanding": 0,
        "category": null,
        "bookValue": 2.965,
        "priceToBook": 0.86003375,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-09-30T00:00:00.000Z",
        "netIncomeToCommon": -14428000,
        "trailingEps": -1.283,
        "forwardEps": -8.8,
        "lastSplitFactor": "1:18",
        "lastSplitDate": "2019-04-04T00:00:00.000Z",
        "enterpriseToEbitda": 0.57,
        "52WeekChange": 0.25,
        "SandP52WeekChange": -0.16598755
    },
    "summaryProfile": {
        "address1": "10170 Church Ranch Way",
        "address2": "Suite 100",
        "city": "Westminster",
        "state": "CO",
        "zip": "80021",
        "country": "United States",
        "phone": "720 940 2200",
        "website": "https://www.arcabio.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.",
        "fullTimeEmployees": 17,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 2.55,
        "recommendationKey": "none",
        "totalCash": 43939000,
        "totalCashPerShare": 3.049,
        "ebitda": -13918000,
        "totalDebt": 409000,
        "quickRatio": 22.684,
        "currentRatio": 22.999,
        "debtToEquity": 0.957,
        "returnOnAssets": -0.16568,
        "returnOnEquity": -0.29052,
        "freeCashflow": -8566250,
        "operatingCashflow": -14365000,
        "grossMargins": 0,
        "ebitdaMargins": 0,
        "operatingMargins": 0,
        "profitMargins": 0,
        "financialCurrency": "USD"
    }
}